Baseline clinical characteristics of postmenopausal women with osteoporosis and an inadequate clinical response to osteoporosis drugs in the observational study of severe osteoporosis (OSSO).

Baseline clinical characteristics of postmenopausal women with osteoporosis and an inadequate clinical response to osteoporosis drugs in the observational study of severe osteoporosis (OSSO).

Bibliographic Details
Main Authors:	Sykes, D, Cooper, C, Adami, S, Fardellone, P, Jakob, F, Melo-Gomes, J, Martin-Mola, E, Nicholson, T, Thalassinos, N, Torgerson, D, Marin, F
Format:	Conference item
Published:	2005

Similar Items

Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
by: Jakob, F, et al.
Published: (2006)

Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
by: Cooper, C, et al.
Published: (2008)

Incident fractures in patients with inadequate response to antiresorptive osteoporosis therapy: One-year results from the OSSO study
by: Cooper, C, et al.
Published: (2006)

Inadequate Response to Osteoporosis Treatment
by: Ayşegül Yaman, et al.
Published: (2014-08-01)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
by: Delmas, P, et al.
Published: (2005)

BREASTFEEDING AND POSTMENOPAUSAL OSTEOPOROSIS
by: Horia Lăzărescu, et al.
Published: (2019-09-01)

Botanicals in Postmenopausal Osteoporosis
by: Wojciech Słupski, et al.
Published: (2021-05-01)

Hypercalciuria in Postmenopausal Osteoporosis
by: Ayfer Kanberoğlu, et al.
Published: (2004-06-01)

Osteoporosis in postmenopausal women
by: Harvey, M, et al.
Published: (2002)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

REASONS FOR STOPPING ANTI-OSTEOPOROSIS MEDICATIONS AMONG POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
by: Hooven, F, et al.
Published: (2010)

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
by: Lundkvist, J, et al.
Published: (2006)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
by: Kanis, J, et al.
Published: (1997)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
by: Cooper, C, et al.
Published: (2012)

Pathogenesis and treatment of postmenopausal osteoporosis
by: Milhaud, G, et al.
Published: (1983)

Yeast Hydrolysate and Postmenopausal Osteoporosis
by: Yang Hee Hong, et al.
Published: (2023-02-01)

Postmenopausal osteoporosis: Our experience
by: R N Mehrotra, et al.
Published: (2012-01-01)

Primary osteoporosis in postmenopausal women
by: Meng-Xia Ji, et al.
Published: (2015-03-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Treatment options for postmenopausal osteoporosis
by: Walsh GM
Published: (2012-08-01)

HYPERTENSION AND OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Marina Rašić Popović, et al.
Published: (2009-04-01)

Application of Osteorisk to postmenopausal patients with osteoporosis
by: Marcelo Luis Steiner, et al.

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
by: Pazianas, M, et al.
Published: (2010)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Michael Pazianas, et al.
Published: (2010-07-01)

Experience in using Prolia in patients with postmenopausal osteoporosis in clinical practice
by: I A Skripnikova, et al.
Published: (2017-12-01)

Awareness of osteoporosis in postmenopausal Indian women: An evaluation of Osteoporosis Health Belief Scale
by: Nirmal Raj Gopinathan, et al.
Published: (2016-01-01)

Osteoporosis posmenopausia según densitometría ósea Postmenopausal osteoporosis according to bony densitometry
by: Dayana Couto Núñez, et al.
Published: (2011-12-01)

DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
by: Gauthier, A, et al.
Published: (2009)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2008)

Development and validation of a disease model for postmenopausal osteoporosis.
by: Gauthier, A, et al.
Published: (2011)

Natural remedies for osteoporosis in postmenopausal women.
by: Del Mar Christopher, B, et al.
Published: (2002)

Yearly zoledronic acid in postmenopausal osteoporosis.
by: Poole, K, et al.
Published: (2007)

Serum IL-17 and postmenopausal osteoporosis
by: Tharwa H. AL-Tai
Published: (2016-01-01)

Effect of Teriparatide in Postmenopausal Women with Osteoporosis
by: Masoud Shayestehazar, et al.
Published: (2018-12-01)

Factors associated with osteoporosis in postmenopausal women
by: Talma Reis Leal Fernandes, et al.
Published: (2015-11-01)

Effects of Yogasanas on osteoporosis in postmenopausal women
by: Zainab S Motorwala, et al.
Published: (2016-01-01)

Once-monthly risedronate for postmenopausal osteoporosis
by: Kristina Casadei, et al.
Published: (2009-02-01)

The role of melatonin in the development of postmenopausal osteoporosis
by: Keda Yang, et al.
Published: (2022-10-01)

Association of dyslipidaemia with osteoporosis in postmenopausal women
by: Lingnan Zhang, et al.
Published: (2021-03-01)